Chiron Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-34
Closed -$3K 151
2020
Q3
$3K Buy
+34
New +$3K ﹤0.01% 409